Annual ROE
-61.18%
-29.96%-95.96%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual return on equity is -61.18%, with the most recent change of -29.96% (-95.96%) on December 31, 2023.
- During the last 3 years, LVTX annual ROE has risen by +175.39% (+74.14%).
- LVTX annual ROE is now -95.96% below its all-time high of -31.22%, reached on December 31, 2022.
Performance
LVTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-62.22%
-13.69%-28.21%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly return on equity is -62.22%, with the most recent change of -13.69% (-28.21%) on September 30, 2024.
- Over the past year, LVTX quarterly ROE has increased by +5.43% (+8.03%).
- LVTX quarterly ROE is now -167.50% below its all-time high of -23.26%, reached on September 30, 2022.
Performance
LVTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
LVTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -96.0% | +8.0% |
| 3 y3 years | +74.1% | +8.0% |
| 5 y5 years | +63.1% | +8.0% |
LVTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -96.0% | +9.0% | -167.5% | +8.0% |
| 5 y | 5-year | -96.0% | +74.1% | -167.5% | +69.4% |
| alltime | all time | -96.0% | +74.1% | -167.5% | +69.4% |
LAVA Therapeutics NV ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -62.22%(+28.2%) |
| Jun 2024 | - | -48.53%(+0.4%) |
| Mar 2024 | - | -48.35%(-23.8%) |
| Dec 2023 | -61.18%(+96.0%) | -63.41%(-6.3%) |
| Sep 2023 | - | -67.65%(+37.2%) |
| Jun 2023 | - | -49.31%(+25.0%) |
| Mar 2023 | - | -39.46%(+23.5%) |
| Dec 2022 | -31.22% | -31.94%(+37.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -23.26%(-17.5%) |
| Jun 2022 | - | -28.18%(+6.9%) |
| Mar 2022 | - | -26.37%(-35.5%) |
| Dec 2021 | -67.24%(-71.6%) | -40.88%(+8.5%) |
| Sep 2021 | - | -37.67%(-1.1%) |
| Jun 2021 | - | -38.08%(-14.1%) |
| Mar 2021 | - | -44.34%(-78.2%) |
| Dec 2020 | -236.57%(+42.7%) | -203.31% |
| Dec 2019 | -165.76% | - |
FAQ
- What is LAVA Therapeutics NV annual return on equity?
- What is the all time high annual ROE for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual ROE year-on-year change?
- What is LAVA Therapeutics NV quarterly return on equity?
- What is the all time high quarterly ROE for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly ROE year-on-year change?
What is LAVA Therapeutics NV annual return on equity?
The current annual ROE of LVTX is -61.18%
What is the all time high annual ROE for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual return on equity is -31.22%
What is LAVA Therapeutics NV annual ROE year-on-year change?
Over the past year, LVTX annual return on equity has changed by -29.96% (-95.96%)
What is LAVA Therapeutics NV quarterly return on equity?
The current quarterly ROE of LVTX is -62.22%
What is the all time high quarterly ROE for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly return on equity is -23.26%
What is LAVA Therapeutics NV quarterly ROE year-on-year change?
Over the past year, LVTX quarterly return on equity has changed by +5.43% (+8.03%)